Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG

Parasitology

Volumn 116, Issue 3, 1998, Pages 219-221

  Dube, Anuradha ^a   Sharma, P ^a   Srivastava, J K ^a   Misra, A ^a   Naik, S ^b   Katiyar, J C ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BCG; Cross protection; Indian langur monkeys; L. donovani; Leishmania major; Vaccination

Indexed keywords

BCG VACCINE; LEISHMANIA VACCINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HAMSTER; INFECTION CONTROL; INFECTION PREVENTION; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIA DONOVANI; LEISHMANIASIS; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; TUBERCULOSIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CERCOPITHECIDAE; CRICETINAE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; INDIA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS, VISCERAL; MALE; PROTOZOAN VACCINES; SPLEEN; VACCINATION; VACCINES, INACTIVATED;

ACTINOBACTERIA (CLASS); ANIMALIA; CRICETINAE; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MYCOBACTERIUM BOVIS BCG; NASO HEXACANTHUS; PRESBYTIS ENTELLUS; PROTOZOA; UNCULTURED ACTINOMYCETE;

EID: 0031934169     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182097002175     Document Type: Article

References (17)

1. ADLER, S. & GUNDERS, A. E. (1964). Immunity to Leishmania mexicana following spontaneous recovery from oriental sore. Transactions of the Royal Society of Tropical Medicine and Hygiene 58, 274-277.
2. ALEXANDER, J. (1982). A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 648-649.
3. ANURADHA, PAL, R., GURU, P. Y., KATIYAR, J. C. & SETHI, N. (1990). Successful transmission of Leishmania donovani in Indian langurs (Presbytis entellus). Current Science 59, 612-615.
4. ANURADHA, PAL, R., ZEHRA, K., KATIYAR, J. C., SETHI, N., BHATIA, G. & SINGH, R. K. (1992). The Indian langur: preliminary report of a new non-human primate host for visceral leishmaniasis. Bulletin of the World Health Organization 70, 63-72.
5. BADARO, R., JONES, T. C., CARVALHO, E. M., SAMPIO, D., REED, S. G., BARVAL, A., TEIXEIRA, R. & JOHNSON, W. D. (1986). New perspective on subclinical forms of visceral leishmaniasis. Journal of Infectious Diseases 154, 1003-1011.
6. ENGVALL, E. & PERLMANN, P. (1972). Enzyme linked immunosorbent assay (ELISA). Quantitation of specific antibodies by enzyme labelled anti-immunoglobulin in antigen coated tubes. Journal of Immunology 109, 129-135.
7. GICHERU, M. M., OLOBO, J. O. & ANJILI, C. O. (1996). Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Experimental Parasitology 85, 109-116.
8. GREENBLATT, C. L. (1988). Cutaneous leishmaniasis: the prospect for a killed vaccine. Parasitology Today 4, 53-57.
9. KURTHZALS, J. A. L., HEY, A. S., THEANDER, T. G., ODERA, E., CHRISTENSON, C. B. V., GITHURE, J. I., KOECH, D. K., SCHAEF, K. U., HANDMAN, E. & KHARAZM, A. (1992). Cellular and humoral immune reactivity of a population in Baringo district of Kenya to Leishmania promastigotes lipophosphoglycan. American Journal of Tropical Medicine and Hygiene 46, 480-488.
10. LAINSON, R. & SHAW, J. J. (1966). Studies on the immunology and serology of leishmaniasis. III. On the cross-immunity between Panamanian cutaneous leishmaniasis and Leishmania mexicana infection in man. Transactions of the Royal Society of Tropical Medicine and Hygiene 60, 533-535.
11. MAUEL, J. & BEHIN, R. (1982). Leishmaniasis immunity, immunopathology and immunodiagnosis. In Immunity to Parasitic Infections (ed. Cohen, S. & Waren, K. S.) pp. 3443-3463. Blackwell Scientific Publications, Oxford.
12. MITCHELL, G. F. & HANDMAN, E. (1987). Heterologous protection in murine cutaneous leishmaniasis. Immunology and Cell Biology 65, 387-392.
13. MODABBER, F. (1990). Development of vaccines against Leishmaniasis. Scandinavian Journal of Infectious Diseases (Suppl.) 76, 72-78.
14. NURIT, R. & JAFFE, C. L. (1993). Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. Journal of Immunology 150, 2322-2331.
15. PAL, R., ANURADHA, GURU, P. Y. & KATIYAR, J. C. (1989). Leishmania donovani in hamster: migration of amastigotes to unusual sites following drug therapy. Medical Science Research 17, 579-581.
16. ROSSELL, R. A., BRAY, R. S. & ALEXANDER, J. (1987). The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunology 9, 105-115.
17. SACKS, D. L., LAL, S. L., SHRIVASTAVA, S. N., BLACKWELL, J. & NEVA, F. A. (1987). An analysis of T-cell responses in Indian Kala-azar. Journal of Immunology 138, 908-913.